NICE has updated its guidance on stroke rehabilitation, and now recommends that stroke patients are offered at least three hours of needs-based rehabilitation at least five times per week.
Fremanezumab (Ajovy) has the potential to reduce the symptoms and cumulative burden of migraine and associated depression, according to new research.
Patients diagnosed with atrial fibrillation post-stroke generally have fewer associated health conditions, according to new research.
A new analysis predicts that nearly 10 million people will die from stroke every year by 2050, rising from just 6.6 million annual deaths in 2020.
In part one of this two-part series, we speak to three experts in the field of dementia about whether eating a healthy, balanced diet could help stave off Alzheimer's disease.
The first direct-to-consumer screening test, which identifies people who are potentially at risk of developing Alzheimer's disease, has been launched in the United States.
This case study discusses a patient who was admitted to the stroke unit. The patient was found to be face, arm, speech test (FAST) positive and was referred to the TIA clinic. But after more tests were conducted, he was diagnosed with…
Dr Harry Brown reviews Emergency Neurology, which is suitable for junior and more experienced neurology staff.
Super-agers (i.e. those who can recall everyday events and life experiences as well as someone 20 to 30 years younger) move more quickly and have better mental health than typical older adults, according to a new study.
People who have a bowel movement every three days or more are at increased risk of cognitive decline, according to new research presented at the Alzheimer’s Association International Conference (AAIC) in Amsterdam.
The results of a Phase 3 trial show that Eli Lilly’s Alzheimer’s drug, donanemab, can significantly slow down functional decline.
Parkinson's disease (PD) is a recognisable clinical syndrome that represents a fast-growing neurodegenerative condition and there is a worldwide rising prevalence. This article highlights the recent updates in the diagnosis and management.
A new treatment for Alzheimer’s disease is able to safely and successfully lower levels of tau – a protein predominantly found in brain cells that is thought to be a cause of the disease.
Around 145,000 people live with Parkinson’s disease in the UK and it is the fastest growing neurological condition in the world. This article is an overview of diagnosis and current treatment options.
Identifying an abnormal build-up of protein deposits on the brain could help to catch Parkinson’s disease early, according to the largest study to date, published in The Lancet Neurology journal.